*Disseminated on Behalf of Intelligent Bio Solutions Inc. Please see disclosures below. |
| "INBS" Takes on Testing Industry Giants |
| | | | | Folks, Drug testing in the workplace has traditionally meant urine cups, supervised bathroom visits, and waiting days for results.
Intelligent Bio Solutions (INBS) is attempting to change that with a system that can detect drug use through something far simpler: a fingerprint.
The Problem With Traditional Drug Testing
Workplace drug testing has long been an awkward necessity for many industries. The standard approaches—urine and saliva testing—come with well-known drawbacks.
They require specialized facilities, trained collectors, and biohazardous waste disposal. They can feel invasive and undignified for employees. And crucially, they often detect drug use from days or even weeks earlier, making it difficult to determine whether someone is actually impaired at work right now.
Meanwhile, the scope of the problem continues to grow. According to the UNODC World Drug Report 2025, approximately 316 million people used drugs in 2023, representing a 28% increase over the past decade. In the United States alone, more than 70% of people who abuse alcohol or illicit drugs are employed, creating ongoing safety concerns across industries from construction to transportation. | | | How Fingerprint Drug Testing Works
Intelligent Bio Solutions has developed what it calls the Intelligent Fingerprinting Drug Screening System.
The technology analyzes metabolites—the byproducts left behind after the body processes drugs—that are naturally excreted through sweat in the fingertips.
The testing process is straightforward:
1. The person being tested places each fingertip on a collection cartridge for about five seconds 2. An administrator inserts the cartridge into a portable digital reader 3. Results appear in less than 10 minutes
The system screens for substances commonly found in workplace settings, including opiates, cocaine, methamphetamine, and cannabis. According to company data, accuracy reaches up to 99%.
Cost and Speed Advantages
One of the most compelling aspect of the fingerprint approach is the practical advantages it offers over traditional methods. Based on company estimates for 80 drug tests per year (including labor, consumables, and follow-up costs), the numbers look like this:
- Fingerprint testing: approximately $5,500 annually, results in under 10 minutes
- Saliva testing: approximately $7,600 annually, results in up to 20 minutes
- Urine testing: approximately $7,750 annually, results in 20 minutes to 4 hours or more
| | | Key Benefits for Employers...
- No specialized facilities required—testing can happen anywhere with the portable system
- No biohazardous waste to dispose of, unlike urine or saliva samples
- Sample integrity is maintained through administrator-supervised testing and self-locking seals
- Employee dignity is preserved through a quick, non-invasive process
- Batch testing capability allows multiple samples to be analyzed in 2-3 minutes each
Market Opportunity and Growth
The global drug screening market was valued at $12.6 billion in 2024 and is projected to reach $31.8 billion by 2030 (according to Research and Markets).
Several factors are driving this expansion, including stronger workplace safety regulations, rising substance abuse rates, and increased awareness of safety implications in high-risk industries.
The company has already established commercial traction, with 480+ active customer accounts spread across 27 countries and more than 1,700 readers installed globally. Its customer base spans industries including construction, manufacturing, transportation, utilities, and logistics. | | | Expanding the Product Line
Beyond the fingerprint system, Intelligent Bio Solutions has also developed the SmarTest Sweat Drug Testing Patch.
This wearable device attaches to the upper arm and enables continuous drug monitoring over a 7-10 day period. It collects sweat in real time to detect a broad range of substances—potentially useful for corrections, probation monitoring, or court-mandated rehabilitation programs.
Target Markets Beyond the Workplace
While workplace testing represents INBS's core market, there are additional opportunities in government and law enforcement applications:
- Public safety and compliance initiatives
- Border security and customs screening
- Corrections, probation, and parole monitoring
- Police recruitment and ongoing compliance testing
- Roadside drug testing
- Court-mandated rehabilitation screening
Currently, the fingerprint drug screening system is available for "Forensic Use Only" in the United States.
However, Intelligent Bio Solutions is preparing for FDA clearance that would allow expansion into the broader U.S. drug screening market. This represents a significant potential catalyst, as the American market for workplace drug testing is substantial. | | | Risks to Keep In Mind
As with any small-cap medical technology company, there are important risks to consider...
Regulatory approval in the U.S. is not guaranteed, and the timeline remains uncertain. The company faces competition from established drug testing providers. Achieving profitability will require continued customer acquisition and market penetration.
A Testing Method Worth Watching?
Intelligent Bio Solutions is attempting to solve a genuine problem: making drug testing faster, cheaper, less invasive, and more focused on current impairment. With an established international customer base and a clear path toward U.S. market expansion, the company has moved beyond the purely speculative stage.
Whether the fingerprint approach can gain meaningful market share against entrenched competitors remains to be seen.
But for those interested in the intersection of workplace safety technology and medical devices, INBS offers an unconventional approach to a persistent problem that may be worth following as the company pursues FDA clearance and continues its global expansion.
Anyways...
That's all for now!
Until Next Time, -ZT Team | P.S. Want our text alerts? Text "ZIPTRADER" to 1-(855)-228-1598 to sign up!
(standard carrier data/text rates apply) |
|
|
|---|
|
*Disseminated on Behalf of Intelligent Bio Solutions Inc. Please see disclosures below. |
|
|---|
|
| | 5101 SANTA MONICA BLVD STE 8 #62, 90029, LOS ANGELES, CA |
| You've received it because you've subscribed to our newsletter or are a member of ZipTraderU. |
| This email was sent to reunisoft.cryptonews@blogger.com |
| *SPONSORED CONTENT* ZipTrader LLC is a publishing company, we are not financial advisors. This is not financial advice. Investments involve risk and are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance. ZipTrader has been compensated fifteen thousand USD by ACH Bank Transfer by TD Media LLC to distribute media via email and SMS on behalf of Intelligent Bio Solutions Inc. (INBS) from December 17, 2025 to December 18, 2025. The reader should assume that paying parties, clients of paying parties, and third parties may own shares and may sell shares during or after this campaign, which could negatively impact the stock price. ZipTrader may receive additional campaigns in the future by TD Media LLC to distribute media for Intelligent Bio Solutions Inc. (INBS). As a result of this advertisement and other marketing efforts, ZipTrader may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of ZipTrader do not hold a position in Intelligent Bio Solutions Inc. (INBS). This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Intelligent Bio Solutions Inc. (INBS), increased trading volume, and possibly an increased share price of Intelligent Bio Solutions Inc. (INBS), which may or may not be temporary and decrease once the marketing arrangement has ended. |
| BY READING THIS EMAIL & ALL ZIPTRADER CONTENT YOU AGREE: This is not financial advice. You must do your own due diligence on all information. ZIPTRADER LLC is a publishing company and we provide general information, opinions, & news coverage to viewers. However – we do not provide personalized financial advice, are not financial advisors, and our opinions are not suitable for all investors. You should not treat any opinion as expressed as a specific inducement to make a particular investment or follow a particular strategy, but just as an opinion. Use at your own risk. Past Performance is not indicative of future results, and any results presented are not typical, and should not be understood as typical. Actual results vary given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. TRADING IS RISKY: Most traders in all markets lose all of their money (and more if they use margin). Most small businesses fail. Do NOT partake in trading, investing, entrepreneurship or any other risky endeavor covered here if you are not prepared with the reality that most fail. We reserve the right to have affiliate relationships with advertisers/sponsors. See Full Terms of Service. See Our Advertisement Disclaimer. |
| | |
|
|
|---|
|
|
|
No comments:
Post a Comment